Gordon Ada

Q: What Schools Are Affiliated With Gordon Ada

Gordon Ada is affiliated with the following schools: University of Sydney, University of Melbourne, Australian National University

Gordon Ada's AcademicInfluence.com Rankings

Gordon Ada

Biology

#3138

World Rank

#4839

Historical Rank

Immunology

#276

World Rank

#287

Historical Rank

Microbiology

#299

World Rank

#345

Historical Rank

biology Degrees

Download Badge

Biology

Gordon Ada's Degrees

PhD Immunology University of Melbourne

Why Is Gordon Ada Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Gordon Leslie Ada AO, FAA was an Australian biochemist best known for his seminal contributions to virology and immunology and his long leadership of the Department of Microbiology at the John Curtin School of Medical Research at the Australian National University, where Peter C. Doherty and Rolf Zinkernagel performed their Nobel winning research in his department. Both Zinkernagel and Doherty held him in high regard, and he was invited by them to attend the Nobel award ceremony and dinner in Stockholm.

(See a Problem?)

Gordon Ada's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Options for the control of influenza III. Cairns, North Queensland, Australia (4-9 May 1996). (1997) (538)
The immune response to influenza infection. (1986) (351)
SINGLE CELL STUDIES ON 19S ANTIBODY PRODUCTION (1964) (289)
The clonal-selection theory. (1987) (260)
An in vitro reaction between labelled flagellin or haemocyanin and lymphocyte-like cells from normal animals. (1969) (221)
Specific Inactivation of Antigen-reactive Cells with 125I-Labelled Antigen (1969) (211)
Vaccines and vaccination. (1988) (205)
ANTIGENS IN IMMUNITY. I. PREPARATION AND PROPERTIES OF FLAGELLAR ANTIGENS FROM SALMONELLA ADELAIDE. (1964) (179)
ANTIGENS IN IMMUNITY. IV. CELLULAR LOCALIZATION OF 125-I- AND 131-I-LABELLED FLAGELLA IN LYMPH NODES. (1964) (142)
Carbohydrate-protein conjugate vaccines. (2003) (137)
Purification and properties of neuraminidase from Vibrio cholerae. (1961) (134)
The immunological principles of vaccination (1990) (115)
Cytotoxic T cells specific for influenza virus-infected target cells. (1977) (110)
Cellular Immune Responses in the Murine Lung to Local Immunization with Influenza A Virus Glycoproteins in Micelles and Immunostimulatory Complexes (Iscoms) (1988) (99)
Antigens in immunity. 8. Localization of 125-I-labelled antigens in the secondary response. (1965) (96)
Antigens in immunity. VII. Analysis of immunological memory. (1965) (95)
Influenza virus-specific antibody-secreting cells in the murine lung during primary influenza virus infection (1986) (91)
Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants. (1986) (84)
The Roles of Influenza Virus Haemagglutinin and Nueleoprotein in Protection: Analysis Using Vaccinia Virus Recombinants (1987) (83)
The nucleic acid content of influenza virus. (1954) (82)
ANTIGENS IN IMMUNITY. III. DISTRIBUTION OF IODINATED ANTIGENS FOLLOWING INJECTION INTO RATS VIA THE HIND FOOTPADS. (1964) (81)
ANTIGENS IN IMMUNITY. II. IMMUNOGENIC PROPERTIES OF FLAGELLA, POLYMERIZED FLAGELLIN AND FLAGELLIN IN THE PRIMARY RESPONSE. (1964) (77)
Influenza virus nucleic acid: relationship between biological characteristics of the virus particle and properties of the nucleic acid. (1956) (72)
Behaviour of Active Bacterial Antigens During the Induction of the Immune Response: (I) Properties of Flagellar Antigens from Salmonella (1963) (69)
Low zone tolerance to bacterial flagellin in adult rats: a possible role for antigen localized in lymphoid follicles. (1968) (69)
Role of T-cell function in recovery from murine influenza infection. (1979) (66)
Correlation of grain counts with radioactivity (125I and tritium) in autoradiography. (1966) (63)
Persistence of influenza virus-specific antibody-secreting cells and B-cell memory after primary murine influenza virus infection. (1987) (60)
Properties of the colony stimulating factor in leukaemic and normal mouse serum. (1968) (59)
The separation and quantitative determination of the component sugars of mucoproteins. (1956) (57)
ANTIGENS IN IMMUNITY. V. THE ABILITY OF CELLS IN LYMPHOID FOLLICLES TO RECOGNIZE FOREIGNNESS. (1964) (55)
ANTIGENS IN IMMUNITY. IX. THE ANTIGEN CONTENT OF SINGLE ANTIBODY-FORMING CELLS. (1965) (53)
Recombinant vaccinia viruses as vaccines (1986) (53)
Induction of natural killer cells during murine influenza virus infection. (1981) (52)
Overview of vaccines and vaccination (2005) (51)
Matrix protein expressed at the surface of cells infected with influenza viruses (1977) (50)
Specificity, Ly phenotype, and H-2 compatibility requirements of effector cells in delayed-type hypersensitivity responses to murine influenza virus infection (1980) (46)
Different functions of subsets of effector T cells in murine influenza virus infection. (1982) (45)
Effect of helper T cells on the primary in vitro production of delayed- type hypersensitivity to influenza virus (1981) (44)
The component sugars of the influenza-virus particle. (1956) (41)
Strategies for exploiting the immune system in the design of vaccines. (1991) (40)
Cleavage of bacterial flagellin with cyanogen bromide. Antigenic properties of the protein fragments. (1969) (40)
ANTIGENS IN IMMUNITY (1965) (39)
HIV type 1 vaccine-induced cytotoxic T cell responses: potential role in vaccine efficacy. (1997) (38)
AN IMMUNOLOGICAL STUDY OF AVIAN, VIRAL AND BACTERIAL NEURAMINIDASE BASED ON SPECIFIC INHIBITION OF ENZYME BY ANTIBODY. (1963) (38)
Cleavage of bacterial flagellin with cyanogen bromide. Chemical and physical properties of the protein fragments. (1969) (38)
The Tissue Localization, Immunogenic, and Tolerance-Inducing Properties of Antigens and Antigen-Fragments (1967) (36)
Antibody-mediated enhancement of hormone activity. (1989) (36)
A morphological examination of antigen reactive cells from mouse spleen and peritoneal cavity. (1969) (35)
Phospholipin metabolism in rabbit-liver cytoplasm. (1949) (35)
Influenza-specific antibody-secreting cells and B cell memory in the murine lung after immunization with wild-type, cold-adapted variant and inactivated influenza viruses. (1987) (33)
Strategies in vaccine design. (1994) (33)
Cytotoxic T cells recognize very early, minor changes in ectromelia virus-infected target cells. (1976) (32)
Antigens in immunity. X. Induction of immunologic tolerance to Salmonella adelaide flagellin. (1965) (32)
The coming of age of tumour immunotherapy (1999) (32)
Stimulation of the production of neuraminidase in Vibrio cholerae cultures by N-acetylneuraminic acid and sialyl-lactose. (1959) (32)
Biological and physical properties of the Ryan strain of filamentous influenza virus. (1958) (32)
Vaccines, Vaccination and the Immune Response (1997) (31)
Recognition Of Foreignness in Immune and Tolerant Animals (1964) (30)
Behaviour of Active Bacterial Antigens During the Induction of the Immune Response: (II) Cellular Distribution of Flagellar Antigens labelled with Iodine-131 (1963) (30)
In vivo effects of cyclosporine on influenza A virus-infected mice. (1985) (28)
Prospects for a vaccine against HIV (1989) (27)
The incidence of hemocyanin-binding cells in hemocyanin-tolerant rats. (1972) (26)
Protection of mice against influenza virus infection: enhancement of nonspecific cellular responses by Corynebacterium parvum. (1983) (25)
Electrophoretic studies of virus-red cell interaction: mobility gradient of cells treated with viruses of the influenza group and the receptor-destroying enzyme of V. cholerae. (1950) (25)
The tolerance inducing properties in rats of bacterial flagellin cleaved at the methionine residues. (1969) (24)
The ideal vaccine (1991) (23)
Overview of vaccines (1997) (22)
The initiation and early development of autoimmune diseases. (1988) (22)
Properties of the nucleic acid of the Ryan strain of filamentous influenza virus. (1958) (21)
The measurement of haemagglutinin and matrix protein present on the surface of influenza virus infected P815 mastocytoma cells. (1979) (21)
Humoral and cellular responses of mice to infection with a cold-adapted influenza A virus variant (1982) (21)
Studies on the soluble complement fixing antigens of influenza virus. 3. The nature of the antigens. (1954) (20)
Antigen in tissues: I. State of bacterial flagella in lymph nodes of rats injected with isotopically-labelled flagella (1966) (19)
Twenty years into the saga of MHC‐restriction (1994) (19)
NEURAMINIDASE IN TISSUES OF THE CHICK EMBRYO AND CHICK. (1963) (18)
Differences in Localization of Salmonella Flagella in Lymph Node Follicles of Germ-free and Conventional Rats (1968) (18)
Purification and properties of avian neuraminidase. (1963) (17)
The immunology of vaccination (2004) (17)
Purification of the receptor-destroying enzyme of V. cholerae. (1950) (17)
Electrophoretic studies of virus-red cell interaction: relationship between agglutinability and electrophoretic mobility. (1952) (17)
Towards phase III trials for candidate vaccines (1993) (16)
Functional and structural considerations in the recognition of virus-infected cells by cytotoxic T lymphocytes. (1978) (16)
Influenza Virus‐Specific T Cells Fail to Reduce Lung Virus Titres in Cyclosporin‐Treated, Infected Mice (1985) (16)
Antigen in tissues: II. State of antigen in lymph node of rats given isotopically-labelled flagellin, haemocyanin or serum albumin (1966) (15)
The generation of effector T cells in influenza A-infected, cyclosporine A-treated mice. (1985) (14)
Human reproduction: Prospects for developing vaccines to control fertility (1985) (14)
ANTIGENS IN IMMUNITY. XI. THE UPTAKE OF ANTIGEN IN ANIMALS PREVIOUSLY RENDERED IMMUNOLOGICALLY TOLERANT. (1965) (14)
Murray Valley encephalitis virus: preparation of an infective "ribonucleic acid" fraction. (1959) (14)
DNA vaccination (2003) (14)
The molecular size of neuraminidase from Vibrio cholerae (strain 4Z) (1964) (13)
The enunciation and impact of Macfarlane Burnet's clonal selection theory of acquired immunity (2008) (13)
CTL immunity and cytokine regulation in viral infection. (1994) (13)
Prospects for HIV vaccines. (1988) (13)
Roles of influenza virus infectivity and glycosylation of viral antigen for recognition of target cells by cytolytic T lymphocytes. (1981) (12)
HIV: to vaccinate or not to vaccinate? (1992) (11)
Real and imagined dangers (1991) (11)
Studies on the soluble complement fixing antigen of influenza virus. II. Serological behaviour of the antigen. (1953) (11)
What to expect of a good vaccine and how to achieve it. (1988) (11)
The importance of vaccination. (2007) (11)
Prospects for developing vaccines to control fertility. (1985) (10)
Vaccination and the immune response (1991) (10)
Overview of vaccines. (1997) (10)
The action of phospholipase A and lipid solvents on Murray Valley encephalitis virus. (1961) (10)
Immunology: Are peptides good antigens? (1985) (10)
Vaccines for the future? (1982) (9)
Progress towards achieving new vaccine and vaccination goals (2003) (9)
HIV and pandemic influenza virus: two great infectious disease challenges. (2000) (9)
Particle counts and some chemical properties of Murray Valley encephalitis virus. (1962) (9)
Macrophage procoagulant-inducing activity of influenza-specific effector T cells. (1984) (9)
Studies on the complement fixing antigen of influenza virus. I. Purification of antigen. (1952) (9)
Combination vaccines: present practices and future possibilities. (1994) (9)
Some aspects of the reaction between crude Murray Valley encephalitis (MVE) virus and deoxycholate. (1959) (9)
Stimulation of the production of neuraminidase in Vibrio cholerae cultures by N-acetyl-mannosamine. (1959) (9)
Determining the immune mechanisms of protection from AIDS: correlates of immunity and the development of syngeneic macaques (2001) (9)
Generation of influenza virus specific delayed type hypersensitivity T cells in vitro. Secondary effector cells. (1980) (9)
Human vaccines. (1994) (8)
The sensitization of mice with a wild-type and cold-adapted variant of influenza A virus. II. Secondary cytotoxic T cell responses. (1984) (8)
Vaccination: The Facts, the Fears, the Future (2001) (8)
Controlling influenza epidemics. (1981) (7)
Electrophoretic studies of virus-red cell interaction: additive effect of viruses of the influenza group and the receptor-destroying enzyme of V. cholerae. (1950) (7)
The inductive requirements for the primary in vitro generation of delayed-type hypersensitivity response to influenza virus in mice. (1981) (7)
Global aspects of vaccination. (1995) (7)
MICROSCOPIC AND ELECTRON MICROSCOPIC DISTRIBUTION OF ANTIGEN IN LYMPHOID ORGANS (1971) (7)
Lymphocytic Receptors for Antigens (1975) (7)
Overview of vaccines. (1996) (6)
The cell-mediated and humoral responses to influenza virus infection in the mouse lung. (1987) (6)
Specialized Cell Function in the Lymphoid and Reticuloendothelial Cell Series (1967) (5)
Antigen‐Processing Revisited ‐ A Foreword (1987) (5)
Action of the receptor destroying enzyme of V. cholera (RDE) in guinea-pigs. (1954) (5)
THE INTERACTION OF ANTIGEN WITH LYMPHOID CELLS (1971) (5)
The next steps in HIV vaccine development. (1992) (5)
Are peptides good antigens? (1985) (4)
Vaccine development. Real and imagined dangers. (1991) (4)
The acquisition of anti-influenza virus activity by macrophages. (1984) (4)
Purification of Murray Valley encephalitis virus. (1961) (4)
Antigen in tissues. 3. The separation of antigen-containing components from lymphoid tissues. (1967) (3)
VACCINES AND IMMUNE RESPONSE (1999) (3)
Do cytotoxic T lymphocytes clear some HIV/SIV infections? (1996) (3)
Vaccination in Third World countries. (1993) (3)
New approaches to vaccine development: memorandum from a WHO meeting. (1985) (3)
MHC restriction of anti-viral immunity. (1981) (3)
The design and testing of HIV prophylactic vaccines. (1992) (3)
ANTIBODIES AND THE AFFERENT LIMB OF THE IMMUNE RESPONSE (1971) (2)
DNA immunization (1997) (2)
Behaviour of active bacterial antigens during the induction of the immune response. (1) Properties of flagellar antigens from Salmonella. (2) Cellular distribution of flagellar antigens labelled with iodine-131 (1964) (2)
The Infectivity of Preparations made by the Action of Phenol on Dengue I, Dengue II, GD VII and Herpes Simplex Viruses. (1959) (2)
Sensitization of mice with wild-type and cold-adapted influenza virus variants: immune response to two H1N1 and H3N2 viruses (1985) (2)
SIALIC ACID IN THE KEILIN-HARTREE CYTOCHROME C PREPARATION FROM BEEF-HEART MUSCLE. (1963) (2)
Vaccines and the challenge of parasitic infections. (1993) (2)
The Mechanism of Antigen Localization in Lymphoid Follicles and the Patterns of Localization of Tolerance-Inducing Flagellar Proteins (1971) (2)
Desirable Immunologic Characteristics for the Development of an Ideal Vaccine (1994) (2)
THE FUNCTIONAL ANATOMY OF THE LYMPHOID SYSTEM (1971) (2)
In vivo effects of cyclosporine in the generation and expression of effector cell function. (1986) (2)
Children's vaccine initiative ad hoc committee on an investment strategy for measles control (1994) (1)
IMMUNE RESPONSE | General Features (1999) (1)
Delayed‐Type Hypersensitivity in the Mouse (1972) (1)
Exploring the unknown: the challenges of a career in biomedical research (2000) (1)
Some Current and Future Developments in Biology Using Recombinant DNA Technology (1985) (1)
Frank Macfarlane Burnet: virologist, immunologist and Nobel Prize winner (1999) (1)
Relationship of antigen to the formation of antibodies. (1966) (1)
Changes in the Surface of Virus‐Infected Cells Recognized by Cytotoxic T Cells (1976) (1)
Bacterial Flagellin as an Antigen and Immunogen (1972) (1)
SUPPRESSOR ACTIVITY IN MICE TOLERANT OF HEMOCYANIN (1974) (1)
Modern Trends in Immunology I (1964) (1)
GERM WARFARE: BREAKTHROUGHS IN IMMUNOLOGY (2000) (1)
Antigens, Lymphoid Cells and the Immune Response (2014) (1)
THE ROLE OF ANTIGEN IN IMMUNOLOGICAL TOLERANCE (1971) (1)
Delayed-type hypersensitivity in the mouse. 3. Inactivation of thymus-derived effector cells and their precursors. (1972) (1)
Host factors important in immune surveillance against tumours. (1982) (1)
The contribution of virus infections to our understanding of the immune system. (1989) (1)
Annual review of microbiology, Vol. 37 (1984) (0)
Ribonucleic Acid in Influenza Virus (2008) (0)
Are cytotoxic T cells a common homeostatic mechanism in responses to viruses, homografts and tumours? (1978) (0)
INTERACTION OF ANTIGENS WITH CELLS OF THE RETICULOENDOTHELIAL SYSTEM (1971) (0)
What cells tell us about molecules (1978) (0)
BEHAVIOR PATTERNS OF LYMPHOID CELLS (1971) (0)
CHALLENGES OF CHRONIC PERSISTING INFECTIONS OF GLOBAL IMPORTANCE FOR VACCINE DEVELOPERS (1999) (0)
Cancer, virus infections and the immune response (1978) (0)
INTRODUCTION: CENTRAL QUESTIONS IN CELLULAR IMMUNOLOGY (1971) (0)
A commentary on the first international conference on engineered vaccines for cancer and AIDS; the "coming of age" of tumor immunology. (1994) (0)
HIV. Towards phase III trials for candidate vaccines. (1993) (0)
Medical graduates and scientific research in Australia: a personal reflection (2004) (0)
ANTIGEN AND LYMPHOID CELLS—A SYNTHESIS AND PROSPECTS (1971) (0)
Comparative Immunology. Edwin L. Cooper (1977) (0)
The Reaction of Antigen With Lymphocytes (1973) (0)
Modern approaches to vaccine development with special reference to the needs of developing countries. (1988) (0)
Stimulation of the Production of Neurarninidase in Vibrio cholerae Cultures by N-Acetylmannosamine (2008) (0)
Vaccination, Methods of Administration (1998) (0)
The Potential Hazards of Recombinant DNA Research: Their Assessment and Management (1977) (0)
Vaccines, Adverse Reactions to (1998) (0)
ORGAN DISTRIBUTION OF ANTIGENS (1971) (0)
Evidence for Radioresistant Helper Cells for Primary DTH Response Generated to Influenza Virus In Vitro (2003) (0)
International Review of Experimental Pathology (1986) (0)
Chairman's Summing‐Up (2007) (0)
SIV and HIV prophylaxis (1996) (0)
Letter from Gordon L. Ada to Joshua Lederberg (1977) (0)
On the Importance of Developing a Vaccine to Control Human Fertility (1986) (0)
Recombinant vectors in vaccine development. The next steps. (1994) (0)
The antigens, Volume 7: Editor M. Sela, Academic Press, New York, 1988, $95.00 (1989) (0)
How do vaccinia-vectored vaccines fit into human immunization programmes? (1989) (0)
Stimulation of the Production of Neurarninidase in Vibrio cholerae Cultures by N-Acetylmannosamine (2008) (0)
Vaccination in Third World countries [editorial] (1993) (0)
Neuraminidase in the choriosllantois of the chick embryo. (1961) (0)
Antigen-processing revisted ― a foreword (1987) (0)
Influenza — to vaccinate or not to vaccinate? (1987) (0)
Lymphoid cell receptors and antigen recognition. (1976) (0)
The Challenge of Chronic and Persisting Infections for Vaccine Development (1990) (0)
Stimulation of the Production of Neurarninidase in Vibrio cholerae Cultures by N-Acetylmannosamine (2008) (0)
The Fate of Antigens in Vivo (1971) (0)
ANTIBODY PRODUCTION AND TOLERANCE IN DISSOCIATED CELL SYSTEMS (1971) (0)
Immunization (contemporary issues in infectious diseases vol. 8) (1990) (0)
Approaches to viral vaccine development involving chemokine receptors and their ligands, with special reference to Human Immunodeficiency Virus 1 (2004) (0)
EJeetrophoretic Studies of Virus-Red Cell Interaction : Additive Effect of Viruses of the Influenza Group and the Receptor-Destroying Enzyme of. (1950) (0)
The production and role of cytotoxic T cells in influenza virus infection in mice: do the same rules apply in the response to any foreign antigen? (1979) (0)

This paper list is powered by the following services:

Other Resources About Gordon Ada

en.wikipedia.org

What Schools Are Affiliated With Gordon Ada?

Gordon Ada is affiliated with the following schools:

Gordon Ada's Academic­Influence.com Rankings

Gordon Ada's Degrees

Why Is Gordon Ada Influential?

Gordon Ada's Published Works

Published Works

Other Resources About Gordon Ada

What Schools Are Affiliated With Gordon Ada?

Gordon Ada's AcademicInfluence.com Rankings